Trial intelligence / Profile preview

Ramelteon for prevention of postoperative delirium after gastrectomy in elderly patients

jRCTs041200062Phase 2Recruiting

Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of ramelteon in postoperative delirium (POD) (2 arms). Primary endpoint: Incidence of postoperative delirium. Started Feb 2021; status: recruiting.

02

Drugs

ramelteon
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on jRCTs041200062.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041200062.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call